A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05141721 |
Recruitment Status :
Active, not recruiting
First Posted : December 2, 2021
Last Update Posted : December 22, 2023
|
Sponsor:
Gritstone bio, Inc.
Information provided by (Responsible Party):
Gritstone bio, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | March 2027 |
Estimated Study Completion Date : | March 2027 |